Low Density Lipoprotein Cholesterol Target Goal Attainment Rate and Physician Perceptions about Target Goal Achievement in Korean Patients with Diabetes

被引:19
作者
Hwang, Jenie Yoonoo [1 ]
Jung, Chang Hee [1 ]
Lee, Woo Je [1 ]
Park, Cheol Young [2 ]
Kim, Sung Rae [3 ]
Yoon, Kun-Ho [3 ]
Lee, Moon Kyu [4 ]
Park, Sung Woo [2 ]
Park, Joong-Yeol [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, 388-1 Poongnap 2 Dong, Seoul 138736, South Korea
[2] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea
[3] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea
关键词
Diabetes mellitus; type; 2; Hypercholesterolemia; Surveys;
D O I
10.4093/dmj.2011.35.6.628
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study aims to investigate the discrepancy between clinicians' perceptions and actual achievement rates of low density lipoprotein cholesterol (LDL-C) in Korean patients with diabetes according to updated American Diabetes Association (ADA)/American College of Cardiology Foundation (ACC) recommendations. Methods: This is a multi-center, retrospective, non-interventional, observational study. Diabetic patients aged 18 years or older were eligible if they had been diagnosed with hypercholesterolemia or were receiving a lipid-lowering therapy between May 2010 and August 2010. The information was obtained by reviewing medical records and using a self-completed questionnaire to examine physician perceptions. Results: A total of 2,591 subjects who satisfied the inclusion criteria were enrolled. Highest-risk and high-risk patients accounted for 61.9% and 38.1% of the patients, respectively. Although most (96.3%) underwent a statin monotherapy or a statin-based combination therapy, just 47.4% of patients attained the LDL-C target. However, the physicians' perceptions on target achievement rate (70.6%) were different from the actual results (47.4%). Many patients (65.3%) remained on the starting doses of statins, despite evidence of poor achievement of lipid goals. Conclusion: Only less than half of patients with diabetes attained the LDL-C goal. The surveys showed that poor physician performance might be due to the lack of recognition on ADA/ACC consensus causing a low LDL-C target attainment rate. Therefore, changes in doctor perception are needed to attain target LDL-C level and reduce cardiovascular risk in Korean patients with diabetes.
引用
收藏
页码:628 / 636
页数:9
相关论文
共 27 条
  • [1] The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death - A population-based study of 13000 men and women with 20 years of follow-up
    Almdal, T
    Scharling, H
    Jensen, JS
    Vestergaard, H
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (13) : 1422 - 1426
  • [2] Alzahrani T, 2003, CAN J CARDIOL, V19, P1499
  • [3] Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus - A subgroup analysis of the GREek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study
    Athyros, VG
    Papageorgiou, AA
    Symeonidis, AN
    Didangelos, TP
    Pehlivanidis, AN
    Bouloukos, VI
    Mikhailidis, DP
    [J]. ANGIOLOGY, 2003, 54 (06) : 679 - 690
  • [4] Response to comment on: American Diabetes Association. Standards of medical care in diabetes-2011 (vol 34, pg e54, 2011)
    Wysham, C. H.
    Kirkman, M. S.
    [J]. DIABETES CARE, 2011, 34 (08) : 1887 - 1887
  • [5] Bloomgarden ZT, 2011, DIABETES CARE, V34, P1887, DOI [10.2337/dc11-0840, 10.2337/dc11-1306, 10.2337/dc11-0007, 10.2337/dc11-1557]
  • [6] Lipoprotein management in patients with cardiometabolic risk
    Brunzell, John D.
    Davidson, Michael
    Furberg, Curt D.
    Goldberg, Ronald B.
    Howard, Barbara V.
    Stein, James H.
    Witztum, Joseph L.
    [J]. DIABETES CARE, 2008, 31 (04) : 811 - 822
  • [7] Is diabetes a coronary risk equivalent? Systematic review and meta-analysis
    Bulugahapitiya, U.
    Siyambalapitiya, S.
    Sithole, J.
    Idris, I.
    [J]. DIABETIC MEDICINE, 2009, 26 (02) : 142 - 148
  • [8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [9] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
    Colhoun, HM
    Betteridge, DJ
    Durrington, PN
    Hitman, GA
    Neil, HAW
    Livingstone, SJ
    Thomason, MJ
    Mackness, MI
    Charlton-Menys, V
    Fuller, JH
    [J]. LANCET, 2004, 364 (9435) : 685 - 696
  • [10] Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation
    D'Agostino, RB
    Grundy, S
    Sullivan, LM
    Wilson, P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02): : 180 - 187